Viewing nowEmpagliflozin Tablets 10 mg (Empagliflozin)
Empagliflozin 10mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

MFDS item code 202102081 · Approved 2021.03.05 · Insurance code 646005280
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise therapy to help control blood sugar in adults with type 2 diabetes. It can be administered as monotherapy, and if necessary, combined with other diabetes medications to enhance blood sugar control. It is particularly effective when used in conjunction with metformin, pioglitazone, sulfonylureas, insulin, or DPP-4 inhibitors. If adequate blood sugar control is difficult with monotherapy, adding this medication can help improve treatment efficacy. Additionally, it is used with care in patients with type 2 diabetes who have cardiovascular diseases. In summary, this medication is used to enhance blood sugar control in patients with type 2 diabetes.
The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Elderly patients No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age and older. Initiation of this medicine is not recommended in patients 85 years of age and older because clinical experience is limited (see Precautions for Use, 4. General Precautions).
This medication should not be used in patients with allergies to the active ingredient or other components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This medication is not used in patients with severely impaired kidney function or those undergoing dialysis. Patients with lactose intolerance or certain genetic metabolic disorders should not be given this medication. For patients with slightly impaired kidney function, dose adjustment is necessary, and treatment should be discontinued if function worsens. It should be used cautiously in some heart failure patients and is not recommended for those with severe heart failure. When this medication is used with insulin or insulin secretagogues, there may be a risk of hypoglycemia, so dose adjustments may be needed. This medication can cause side effects such as hypoglycemia, urinary tract infections, genital fungal infections, and increased urination, so caution is advised. Particularly, fluid volume depletion or dehydration symptoms may occur, so elderly patients or those with low blood pressure need to be especially careful. Serious metabolic disorders such as ketoacidosis can occur, so immediate treatment is required if symptoms appear. Cases of liver damage have been reported, so patients with liver function abnormalities need to be cautious. It is recommended not to use this medication during pregnancy, and breastfeeding should be discontinued if the mother is using this drug. Safety and efficacy in children under 18 years have not been established. In the case of overdose, appropriate treatment is necessary, and methods to remove this medication via blood dialysis are not known. This medication may interact with other drugs, so consult a healthcare professional if other medications are being taken. Caution is necessary when driving or operating machinery due to the risk of hypoglycemia. Diabetes patients should pay attention to everyday foot care, as rare severe infections such as perineal necrosis may occur, so symptoms should be carefully monitored.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to keep the storage temperature between 1 and 30 degrees Celsius to maintain the drug's efficacy and safety.
Light yellow, double-sided convex round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEmpagliflozin 10mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.